Bumetanide, a new loop diuretic.
The effect of bumetanide on renal function has been compared with that of furosemide and a placebo in a double-blind study of 9 healthy young men. The sequence for oral administration of the drug was subjected to a random assignation based upon the Latin-square methodology under three different conditions. (1) Normal hydration: The administration of bumetanide (2 mg) produced within the next 4 hr a diuresis comparable to that induced by 80 mg of furosemide. Urinary excretion of sodium, potassium, chloride, calcium, and uric acid also followed comparable patterns. Phosphaturia occurred only under bumetanide. The effect of bumetanide seemed longer lasting. (2) Water loading: The effects of bumetanide and furosemide were comparable with the exception of the phosphaturic effect induced by bumetanide. The action of  both diuretics on the diluting segment of the nephron was well demonstrated by the marked depression of CH2O. (3) Water deprivation: The effects of the two diuretics were comparable, including depression tCH20. In none of these conditions did the placebo produce any significant effect.
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002034:Bumetanide / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003681:Dehydration; D004232:Diuretics / Q000494:pharmacology*; D005665:Furosemide / Q000494:pharmacology; D006801:Humans; D008297:Male; D010919:Placebos; D013997:Time Factors; D014867:Water / Q000494:pharmacology; D014868:Water Deprivation
D004232:Diuretics; D010919:Placebos; D014867:Water; D002034:Bumetanide; D005665:Furosemide